Fortress Biotech sells brokerage firm following Reuters exposé; Tracon contends with another setback in brain cancer
→ In the aftermath of a Reuters report shining a light on its questionable relationship with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
